{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_8632", "batch_size": 260, "batch_pos": 172, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment reports factual financial information, not the threat's impact with high-potency language.", "method": "llm_batch", "batch_id": "batch_2_17044", "batch_size": 260, "batch_pos": 161, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The segment uses 'jumped' and 'climbed' which refer to financial metrics.", "method": "llm_batch", "batch_id": "batch_3_15344", "batch_size": 260, "batch_pos": 137, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "No loaded rhetorical question is present in the text.", "method": "llm_batch", "batch_id": "batch_4_7984", "batch_size": 260, "batch_pos": 133, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports stock performance but contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_18408", "batch_size": 260, "batch_pos": 131, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_15988", "batch_size": 260, "batch_pos": 119, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_16628", "batch_size": 260, "batch_pos": 116, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 8, "answer": "no", "rationale": "The segment describes stock performance, not a capability or preparedness measure.", "method": "llm_batch", "batch_id": "batch_8_6416", "batch_size": 260, "batch_pos": 77, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 9, "answer": "yes", "rationale": "The segment reports stock price changes ('have jumped 48.7%', 'has climbed 10.4%') factually.", "method": "llm_batch", "batch_id": "batch_9_8632", "batch_size": 260, "batch_pos": 191, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
